The main features of randomized clinical trials performed in the field of hypertension treatment are reviewed, based either on the evaluation of clinical events or on the assessment of surrogate outcome measures. The advantages, limitations, and clinical relevance of each approach are highlighted.
|Number of pages||4|
|Journal||Current Hypertension Reports|
|Publication status||Published - Aug 2005|
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine